Research progress of long non-coding RNA in systemic sclerosis
CSTR:
Author:
Affiliation:

1. Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014010, China. 2. Central Laboratory of the First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology(Key Laboratory of Autoimmunity of Inner Mongolia), Baotou 014010. 3. Department of Rheumatology, the First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014010

Clc Number:

R-33

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Accumulating studies have shown that long non-coding RNA (lncRNA) plays major roles in endothelial injury, inflammation, cancer, and autoimmune diseases. Systemic sclerosis (SSc) is an autoimmune disease with an unclear pathogenesis. lncRNA may be involved in the occurrence and development of SSc by regulating immune disorders, microvascular disease, and fibrosis, and may be a biomarker of SSc to predict occurrence, activity and progression of the disease. Therefore, lncRNA may be a novel therapeutic target of SSc.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:November 03,2022
  • Online: August 18,2023
Article QR Code